These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25778993)

  • 1. Discovery of InhA inhibitors with anti-mycobacterial activity through a matched molecular pair approach.
    Kanetaka H; Koseki Y; Taira J; Umei T; Komatsu H; Sakamoto H; Gulten G; Sacchettini JC; Kitamura M; Aoki S
    Eur J Med Chem; 2015 Apr; 94():378-85. PubMed ID: 25778993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening.
    Kinjo T; Koseki Y; Kobayashi M; Yamada A; Morita K; Yamaguchi K; Tsurusawa R; Gulten G; Komatsu H; Sakamoto H; Sacchettini JC; Kitamura M; Aoki S
    J Chem Inf Model; 2013 May; 53(5):1200-12. PubMed ID: 23600706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modification of a novel inhibitor for mycobacterium enoyl-acyl carrier protein reductase assisted by
    Taira J; Nagano T; Kitamura M; Yamaguchi M; Sakamoto H; Aoki S
    Int J Mycobacteriol; 2020; 9(1):12-17. PubMed ID: 32474482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the novel inhibitor for Mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure-activity relationship study of KES4 assisted by in silico structure-based drug screening.
    Taira J; Umei T; Inoue K; Kitamura M; Berenger F; Sacchettini JC; Sakamoto H; Aoki S
    J Antibiot (Tokyo); 2020 Jun; 73(6):372-381. PubMed ID: 32152525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening.
    Izumizono Y; Arevalo S; Koseki Y; Kuroki M; Aoki S
    Eur J Med Chem; 2011 May; 46(5):1849-56. PubMed ID: 21397998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Eur J Med Chem; 2014 Oct; 86():613-27. PubMed ID: 25218910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
    Koseki Y; Kinjo T; Kobayashi M; Aoki S
    Eur J Med Chem; 2013 Feb; 60():333-9. PubMed ID: 23314046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.
    Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M
    Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D
    Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Driven Design and Synthesis of Rhodanine Derivatives as Novel Antibacterials Targeting the Enoyl Reductase InhA.
    Slepikas L; Chiriano G; Perozzo R; Tardy S; Kranjc A; Patthey-Vuadens O; Ouertatani-Sakouhi H; Kicka S; Harrison CF; Scrignari T; Perron K; Hilbi H; Soldati T; Cosson P; Tarasevicius E; Scapozza L
    J Med Chem; 2016 Dec; 59(24):10917-10928. PubMed ID: 26730986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.
    Pauli I; dos Santos RN; Rostirolla DC; Martinelli LK; Ducati RG; Timmers LF; Basso LA; Santos DS; Guido RV; Andricopulo AD; Norberto de Souza O
    J Chem Inf Model; 2013 Sep; 53(9):2390-401. PubMed ID: 23889525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperazine derivatives: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase and SAR studies.
    Rotta M; Pissinate K; Villela AD; Back DF; Timmers LF; Bachega JF; de Souza ON; Santos DS; Basso LA; Machado P
    Eur J Med Chem; 2015 Jan; 90():436-47. PubMed ID: 25461892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical synthesis, biological evaluation and structure-activity relationship analysis of azaisoindolinones, a novel class of direct enoyl-ACP reductase inhibitors as potential antimycobacterial agents.
    Deraeve C; Dorobantu IM; Rebbah F; Le Quéméner F; Constant P; Quémard A; Bernardes-Génisson V; Bernadou J; Pratviel G
    Bioorg Med Chem; 2011 Nov; 19(21):6225-32. PubMed ID: 21975068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme.
    Martinelli LKB; Rotta M; Villela AD; Rodrigues-Junior VS; Abbadi BL; Trindade RV; Petersen GO; Danesi GM; Nery LR; Pauli I; Campos MM; Bonan CD; de Souza ON; Basso LA; Santos DS
    Sci Rep; 2017 Apr; 7():46696. PubMed ID: 28436453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase.
    Wang H; Liu L; Lu Y; Pan P; Hooker JM; Fowler JS; Tonge PJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4782-4786. PubMed ID: 26227776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
    Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.